(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

STADA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

STADA

ST13

US500000079202969

Class

3, 5, 10, 35

Filing

79202969

Registration

5477601

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

43

Latest update

02/20/2026

Trademark type

Combined

Nice classes

3, 5, 10, 35

Filing date

10/27/2016

Registration date

05/29/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/13/2024

Last transaction

02/20/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

61118 Bad Vilbel, DE

Examiner

CAHILL, CLARE GALLAGHER

Law office

L40

Current location

TMEG LAW OFFICE 104

Mark description

The mark consists of the word "STADA" in blue between two red curved lines on a white background.

Holders and representatives

Holders

STADA Arzneimittel AG

Representatives

Charles T. J. Weigell FROSS ZELNICK LEHRMAN & ZISSU, P.C.

Technical classification

Nice Classes

Class 3Class 5Class 10Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Non-medicated soaps; cosmeticsnon-medicated skin care preparations and sun care preparations

Class 5

Pharmaceutical preparationshouse mark for a full line of pharmaceuticals; dietary supplements for humans; diagnostic preparations for medical purposes

Class 10

Blood testing apparatus; Immunochemical testing apparatus for medical use; analyzers for the identification of proteinsantibodies and small molecules from biological samples and clinical chemistry analyzers and immunochemistry analyzers for the analysis of biological samplesall for clinical medical diagnostic purposes; medical apparatus for treating respiratory conditions; vaporizers for medical purposes; inhalers for medical use sold empty; syringes for medical use; health monitoring devices consisting of blood pressure monitorsthermometerspedometers; medical apparatus for introducing pharmaceutical preparations into the human body

Class 35

Wholesale distributorships featuring pharmaceuticalsdietary supplements for humansdiagnostic preparations for medical purposessoapscosmetics

Publications

History of USPTO decisions and trademark events.

43 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

02/19/2026

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

02/02/2026

INPC

INVALIDATION PROCESSED

02/02/2026

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

08/13/2025

C71T

CANCELLED SECTION 71

12/13/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

05/29/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/04/2021

CORV

REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED

01/08/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/10/2019

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/06/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/12/2018

FIMP

FINAL DISPOSITION PROCESSED

09/12/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/29/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

05/29/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/13/2018

PUBO

PUBLISHED FOR OPPOSITION

03/13/2018

GPNX

NOTIFICATION PROCESSED BY IB

03/09/2018

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/21/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/21/2018

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

02/21/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/06/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/17/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/16/2018

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

01/16/2018

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/14/2017

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

09/21/2017

GNFR

FINAL REFUSAL E-MAILED

09/21/2017

CNFR

FINAL REFUSAL WRITTEN

09/21/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/20/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/20/2017

ALIE

ASSIGNED TO LIE

09/17/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/11/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/11/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/11/2017

RFNT

REFUSAL PROCESSED BY IB

04/02/2017

MAFR

APPLICATION FILING RECEIPT MAILED

03/17/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/15/2017

RFRR

REFUSAL PROCESSED BY MPU

03/15/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/14/2017

CNRT

NON-FINAL ACTION WRITTEN

03/13/2017

DOCK

ASSIGNED TO EXAMINER

03/13/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/13/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/09/2017

Continuous trademark protection

Get notified about every new filing that threatens STADA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.